PL2574343T3 - Kompozycja do nanoszenia na skórę i zastosowanie tej kompozycji - Google Patents

Kompozycja do nanoszenia na skórę i zastosowanie tej kompozycji

Info

Publication number
PL2574343T3
PL2574343T3 PL11007992T PL11007992T PL2574343T3 PL 2574343 T3 PL2574343 T3 PL 2574343T3 PL 11007992 T PL11007992 T PL 11007992T PL 11007992 T PL11007992 T PL 11007992T PL 2574343 T3 PL2574343 T3 PL 2574343T3
Authority
PL
Poland
Prior art keywords
compound
same
skin application
skin
application
Prior art date
Application number
PL11007992T
Other languages
English (en)
Inventor
Ali Nahavandi
Original Assignee
Alnapharm Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alnapharm Gmbh & Co Kg filed Critical Alnapharm Gmbh & Co Kg
Publication of PL2574343T3 publication Critical patent/PL2574343T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL11007992T 2011-09-30 2011-09-30 Kompozycja do nanoszenia na skórę i zastosowanie tej kompozycji PL2574343T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11007992.8A EP2574343B1 (de) 2011-09-30 2011-09-30 Zusammensetzung zum Auftragen auf die Haut und Verwendung derselben

Publications (1)

Publication Number Publication Date
PL2574343T3 true PL2574343T3 (pl) 2014-07-31

Family

ID=46851932

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11007992T PL2574343T3 (pl) 2011-09-30 2011-09-30 Kompozycja do nanoszenia na skórę i zastosowanie tej kompozycji

Country Status (33)

Country Link
US (1) US20140234447A1 (pl)
EP (1) EP2574343B1 (pl)
JP (1) JP6034386B2 (pl)
KR (1) KR101954057B1 (pl)
CN (1) CN103841986B (pl)
AP (1) AP2014007596A0 (pl)
AU (1) AU2012314946B2 (pl)
BR (1) BR112014007218B1 (pl)
CA (1) CA2848922C (pl)
CL (1) CL2014000756A1 (pl)
CO (1) CO6930361A2 (pl)
CY (1) CY1115039T1 (pl)
DK (1) DK2574343T3 (pl)
EA (1) EA023746B1 (pl)
ES (1) ES2458124T3 (pl)
GE (1) GEP20166495B (pl)
GT (1) GT201400058A (pl)
HR (1) HRP20140386T1 (pl)
IL (1) IL231589B (pl)
MX (1) MX349493B (pl)
MY (1) MY184014A (pl)
PE (1) PE20141538A1 (pl)
PH (1) PH12014500631B1 (pl)
PL (1) PL2574343T3 (pl)
PT (1) PT2574343E (pl)
RS (1) RS53289B (pl)
SG (1) SG11201400742PA (pl)
SI (1) SI2574343T1 (pl)
SM (1) SMT201400051B (pl)
TN (1) TN2014000102A1 (pl)
UA (1) UA113065C2 (pl)
WO (1) WO2013045031A1 (pl)
ZA (1) ZA201401941B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20131053A1 (it) * 2013-06-25 2014-12-26 Maria Oliva Salviati Composizione che comprende ortica

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5381612A (en) * 1976-12-24 1978-07-19 Fuarumatsuoiteitsushiyu Fuabur Ointment for treating psoriasis vulgaris * lichen and eczema
DE3232136A1 (de) * 1982-08-28 1984-03-01 Ruth Cegla GmbH, 7542 Schömberg Gemisch enthaltend meersalz und/oder salinensalz
MC2056A1 (fr) * 1987-12-23 1990-09-04 Psoricur Ltd Composition therapeutique contre le psoriasis,procede pour sa preparation et utilisation de plantes medicinales qu'elle contient
US5376361A (en) * 1993-01-13 1994-12-27 Perricone; Nicholas V. Method and compositions for topical application to the skin for prevention and/or treatment of radiation-induced skin damage
DE19504914C1 (de) * 1995-02-15 1995-11-16 Goldwell Gmbh Haarwaschmittel
US6752999B2 (en) * 1995-09-20 2004-06-22 Nicholas V. Perricone Method of skin care and/or treatment using lipoic acid
RU2127584C1 (ru) * 1996-02-29 1999-03-20 Коновалов Валерий Николаевич Мазь противовоспалительного, обезболивающего и ранозаживляющего действия (варианты)
RO113110B1 (ro) * 1997-02-13 1998-04-30 Sc Apollo Sa Săpun extrafin
US5997889A (en) * 1998-02-20 1999-12-07 Omnipotent Skin Products, L.L.C. Hand and body creme for the treatment of skin ailments
AU2001249510A1 (en) * 2000-03-27 2001-10-08 Schott Glas New cosmetic, personal care, cleaning agent, and nutritional supplement compositions comprising bioactive glass and methods of making and using the same
US6673756B2 (en) * 2000-09-20 2004-01-06 Symrise Gmbh & Co. Kg Multiphase soaps
ITRM20030204A1 (it) * 2003-04-29 2004-10-30 Provincia Italiana Della Congregazi One Dei Figli Formulazione dermatologica.
US7060306B2 (en) * 2003-11-10 2006-06-13 Springstead Patricia R Skin formulation
US7390507B2 (en) * 2004-04-13 2008-06-24 Ruwart Mary J Compositions and methods for the treatment of radiation burns and other traumatic skin conditions
FR2888497B1 (fr) * 2005-07-13 2010-12-24 Oreal Procede de maquillage et/ou de soin cosmetique
US20080113033A1 (en) * 2006-11-13 2008-05-15 Hrk, Inc. Topical treatment and manufacturing method
DE102007036499A1 (de) * 2007-08-01 2009-02-05 Henkel Ag & Co. Kgaa Naturkosmetisches Haarbehandlungsmittel
FR2956813B1 (fr) * 2010-02-26 2012-07-27 Lea Lab Shampooing et son utilisation

Also Published As

Publication number Publication date
PE20141538A1 (es) 2014-11-18
PH12014500631A1 (en) 2014-05-12
BR112014007218B1 (pt) 2020-12-15
CL2014000756A1 (es) 2014-10-03
DK2574343T3 (da) 2014-04-28
PT2574343E (pt) 2014-05-02
HRP20140386T1 (hr) 2014-08-01
EA023746B1 (ru) 2016-07-29
MX349493B (es) 2017-08-01
BR112014007218A2 (pt) 2017-04-04
CA2848922C (en) 2020-04-07
IL231589A0 (en) 2014-05-28
JP2014527990A (ja) 2014-10-23
EP2574343B1 (de) 2014-01-29
CN103841986B (zh) 2019-09-03
ZA201401941B (en) 2015-09-30
EP2574343A1 (de) 2013-04-03
KR20140090985A (ko) 2014-07-18
CA2848922A1 (en) 2013-04-04
SMT201400051B (it) 2014-07-07
WO2013045031A1 (en) 2013-04-04
NZ623817A (en) 2015-07-31
SI2574343T1 (sl) 2014-06-30
SG11201400742PA (en) 2014-04-28
CY1115039T1 (el) 2016-12-14
MY184014A (en) 2021-03-17
RS53289B (sr) 2014-08-29
US20140234447A1 (en) 2014-08-21
AP2014007596A0 (en) 2014-04-30
GEP20166495B (en) 2016-06-27
TN2014000102A1 (en) 2015-07-01
HK1197037A1 (en) 2015-01-02
ES2458124T3 (es) 2014-04-30
JP6034386B2 (ja) 2016-11-30
EA201400399A1 (ru) 2014-07-30
PH12014500631B1 (en) 2018-10-31
MX2014003846A (es) 2015-01-16
GT201400058A (es) 2015-10-15
KR101954057B1 (ko) 2019-05-22
UA113065C2 (xx) 2016-12-12
CO6930361A2 (es) 2014-04-28
AU2012314946B2 (en) 2017-06-15
AU2012314946A1 (en) 2014-05-15
CN103841986A (zh) 2014-06-04
IL231589B (en) 2019-07-31

Similar Documents

Publication Publication Date Title
ZA201401653B (en) Pyrazol-4yl-heterocyclyl-carboxamide compounds and methods of use
SG10202009963PA (en) Melanin modification compositions and methods of use
IL222227A0 (en) Pyrazol - 4 - heterocyclyl-carboxamide compounds and methods of use
SG11201504049VA (en) Compounds and their methods of use
HUE043894T2 (hu) Koagulációt elõsegítõ vegyületek és alkalmazásuk módszerei
SMT201900433T1 (it) Derivati di c4-monometil triterpenoidi e metodi del loro uso
EP2675471A4 (en) HSA-RELATED COMPOSITIONS AND USE PROCESSES
HRP20180953T1 (hr) Supstituirani 3-haloalilaminski inhibitori za ssao i njihove uporabe
EP2678018A4 (en) COMBINATION OF CHINESE HEMMER AND USES THEREOF
SG10201608374XA (en) Therapeutically Active Compounds And Their Methods Of Use
EP2709999A4 (en) CHINAZOLIN-7-ETHER COMPOUNDS AND ITS APPLICATION
EP2790709A4 (en) HEMOSTATIC ACTIVE SUBSTANCES AND METHOD OF USE THEREOF
EP2784074A4 (en) PYRAZOL CONNECTION AND ITS USE FOR MEDICAL PURPOSES
PH12014500667A1 (en) Compositions for skin exfoliation and use thereof
PL2791244T3 (pl) Receptury klejów i sposób ich stosowania
EP2773343A4 (en) COSMETIC USE OF N-HETEROARYLBISAMIDE ANALOGS AND RELATED COMPOUNDS
EP2680846A4 (en) USE OF N- (4-METHOXYPHENYL) -1-PHENYL-1H-PYRAZOL-3-AMINE AND COMPOUNDS ASSOCIATED THEREWITH
SI2574343T1 (sl) Sestavek za nanos na koĹľo in njegova uporaba
GB201010638D0 (en) Composition for treatment of skin
GB201104632D0 (en) Use of medicament
AU2012900650A0 (en) Compounds and methods of their use
AU2012900651A0 (en) Compounds and methods of their use
GB201104875D0 (en) New compounds and medical uses
GB201104872D0 (en) New compounds and medical uses